{
  "id": 89396,
  "title": "Non-invasive tests for the evaluation of liver fibrosis in MASLD",
  "url": "https://urgent.news/2026/08/03/non-invasive-tests-for-the-evaluation-of-liver-fibrosis-in-masld",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-03T00:00:00.000Z",
  "source": {
    "name": "Nature Medicine",
    "slug": "nature-medicine",
    "url": "https://www.nature.com/articles/s41591-026-04560-x"
  },
  "original_language": "en",
  "account": "The LITMUS imaging study evaluated non-invasive alternatives to liver biopsy in assessing fibrosis and cirrhosis in metabolic dysfunction-associated steatotic liver disease (MASLD). Elastography and elastography-based composite scores proved accurate enough to replace liver biopsy for diagnosing advanced fibrosis and cirrhosis. However, no markers were found to be as effective in diagnosing metabolic dysfunction-associated steatohepatitis (MASH). The study was published in Nature Medicine and is available via subscription.",
  "summary": "Nature Medicine, Published online: 03 August 2026; doi:10.1038/s41591-026-04560-x In the LITMUS imaging study, we assessed non-invasive alternatives to liver biopsy histopathology in metabolic dysfunction-associated steatotic liver disease (MASLD). Elastography and elastography-based composite scores had sufficient diagnostic accuracy to replace liver biopsy histopathology in evaluating advanced…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}